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Summary. Molecular characterization has become an important tool for 
the analysis of viruses including their classification. The manuscript 
focuses on the molecular analysis of two members of the genus pestivirus 
(hog cholera virus, HCV and bovine viral diarrhea virus, BVDV) and of 
the recently discovered porcine reproductive and respiratory syndrome 
virus (PRRSV). The first protein encoded within the single large 
pestivirus ORF is a nonstructural protein with autoproteolytic activity. 
The cleavage site between the protease and the capsid protein pl4 has 
been predicted previously, but recent experimental data indicate that 
processing occurs at a different site. The capsid protein is followed by a 
putative internal signal sequence and three glycoproteins which are part 
of the virion envelope. According to a new proposal for the nomen-
clature of the structural proteins of pestiviruses they are termed C, EO, 
E l and E2. The genomes of BVDV pairs isolated from animals which 
came down with mucosal disease were analyzed. The genomes from 
cytopathogenic (cp) BVD viruses may contain insertions highly homo-
logous to cellular sequences. In addition, cp BVDV may differ from its 
non cytopathogenic (noncp) counterpart by mere rearrangement of viral 
sequences. The disease PRRS, which emerged a few years ago, is caused 
by a single strand RNA virus; the viral genome is of positive polarity and 
has a size of 15 kb. Data concerning morphology, morphogenesis and 
virion composition suggested already that PRRSV belongs to a group of 
so-called arteriviruses which comprises equine arteritis virus (EAV), 
lactate dehydrogenase elevating virus (LDV) and simian hemorrhagic 
fever virus (SHFV). This conclusion has now been confirmed by analysis 
of genome organization, gene expression strategy and by comparison of 
deduced protein sequences. 
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Introduction 
Pestiviruses are causative agents of important animal diseases such as 
hog cholera, bovine viral diarrhea and border disease of sheep. The 
pestivirus genome represents a single-stranded RNA of about 12.5 kb, 
which is of positive polarity. The genomic RNA comprises a single 
large open reading frame [8, 15]; accordingly, membership of the genus 
pestivirus in the family Togaviridae was no longer justified. Instead, 
pestiviruses have recently been reclassified as members of the family 
Flaviviridae which now comprises the genera flavivirus, pestivirus and 
the hepatitis C virus group. These viruses have certain characteristics in 
common like overall genome organization and strategy of gene expres-
sion. Antisera against bacterial fusion proteins and synthetic peptides as 
well as monoclonal antibodies were used to identify proteins encoded by 
pestiviruses [5, 7, 27-30]. Interestingly, the genomes of several cyto-
pathogenic BVDV strains contain insertions highly homologous to 
cellular sequences [16, 17, 19, 23]. 
The porcine reproductive and respiratory syndrome virus (PRRSV) 
has been described as a small enveloped RNA virus [2, 32] with morpho-
logical and morphogenetical similarities to members of the arterivirus 
group, including equine arteritis virus (EAV) and lactate dehydrogenase-
elevating virus of mice (LDV). In addition, relationships between 
PRRSV and arteriviruses are suggested by the nature of permissive cells. 
The arteriviruses infect particular subpopulations of macrophages [21] 
and PRRSV apparently grows exclusively in alveolar lung macrophages. 
However, serological crossreactions could so far not be demonstrated 
between PRRSV and any of the arteriviruses. 
Results and discussion 
Pestiviruses 
a. Hog cholera virus 
Analysis of the autoprotease HCV p23. The nonstructural protein HCV 
p23 represents the first protein of the pestivirus ORF. As already shown 
for BVDV p20 [33], HCV p23 also possesses autoproteolytic activity. A 
precursor molecule consisting of p23 and pl4 could never be demons-
trated even when very short pulse periods were used. This result was 
obtained after infection with HCV as well as different Vaccinia virus/ 
HCV recombinants. Processing was also observed after in vitro transla-
tion of HCV RNA and in vitro transcription/translation experiments 
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Fig. 1. Evidence that HCV p23 possesses proteolytic activity. After linearization of an 
HCV cDNA construct with different restriction enzymes, in vitro transcription/transla­
tion was performed. The proteins were identified after immunoprecipitation by SDS-
PAGE 
with cDNA constructs. The latter experiments also showed that the 
proteolytic activity resides in HCV p23 (Fig. 1). 
For BVDV and HCV it has been proposed that cleavage occurs after 
Trp-164 of the ORF [28, 33] and this assumption was supported by in 
vitro mutagenesis studies [33]. However, there is new evidence indicating 
that cleavage occurs after Cys-168 (Fig. 2). Firstly, pl4 could not be 
labeled with [35S]-cysteine which is absent from pl4 only if cleavage 
occurs after Cys-168. Secondly, the genomic region comprising HCV p23 
and pl4 was expressed in bacteria. In this prokaryotic expression system 
the release of a 14 kD protein was observed. N-terminal sequencing of 
this protein revealed that the protein starts with Ser-169 (manuscript in 
preparation). Further efforts concern characterization of the protease 
and elucidation of its function. 
Interestingly, the analysis of two genomes of cytopathogenic (cp) 
BVDV strains revealed that their genomes contain duplications encom­
passing the autoprotease p20. The 3'-terminal codon of the inserted p20 
coding region is identical in both cp-BVDV genomes and codes for a 
cysteine analogous to Cys-168 of the pestiviral ORF [18]. 
autoprotease p23 • p14 
Asn Cys Pro Leu Trp Val Thr Ser Cys Ser Asp Asp 
160 164^165 168^169 171 
Fig. 2. Cleavage site of pestivirus autoprotease 
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Fig. 3. Suggested nomenclature for structural proteins of pestiviruses 
Structural proteins of HCV 
Within the pestiviral polyprotein the autoprotease HCV p23/BVDV p20 
is followed by the nucleocapsid protein pl4 which has been demonstrated 
for HCV as well as BVDV [28]. The following internal signal sequence 
probably mediates translocation of the first structural glycoprotein, HCV 
gp44/48. Together with gp33 and gp55, the three glycoproteins constitute 
the virion envelope. The glycoproteins form parts of disulfide-linked 
dimers [28, 29]. While gp33 probably represents a transmembrane pro-
tein, the other two glycoproteins both are exposed on the surface of 
virions and induce virus neutralizing antibodies [30]. 
So far, the designation of pestivirus encoded glycoproteins varies 
among different laboratories because most research groups use the 
apparent molecular weights as a basis for nomenclature (Fig. 3). In order 
to obtain a common nomenclature, we suggest to use the abbreviations 
C, EO, E l and E2 for nucleocapsid protein and the glycoproteins, 
respectively (Fig. 3). This approach allows also to have the same desig-
nations for analogous glycoproteins from the hepatitis C virus group 
(Fig. 4). It remains to be seen whether the (glyco)proteins from members 
of the genus flavivirus will be termed accordingly. At this point the 
designation EO (for HCV gp44/48, BVDV gp48) is being debated because 
(1) it is clearly a structural protein of pestiviruses and (2) the "0" may 
be misleading because it is used in other virus systems for precursor 
molecules. It appears that EO represents a unique glycoprotein among 
pestiviruses which is not only a structural protein but also secreted from 
infected cells (manuscript in press). 
In order to determine the processing sites between C and EO as well 
as between the glycoproteins, N-terminal sequencing was performed. 
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Fig. 4. Structural proteins of Flaviviridae 
100 aa 
E O E 1 E 2 
Number of Amino Acids 227 195 373 (?) 
Calculated Molecular Weight (kDa) 25.8 21.8 41.9 
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55 
(gP55) 
Number of Possible 
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Fig. 5. Glycoproteins of hog cholera virus 
For this purpose the glycoproteins were purified from virus infected cells 
by immunoaffinity columns using monoclonal antibodies against EO and 
E2. E l was copurified with E2 because of the linkage of the two 
glycoproteins by disulfide bridges. The results of N-terminal sequencing 
allow important conclusions concerning the three glycoproteins, namely 
the actual sizes of the protein backbones and the calculated contribution 
of carbohydrate moieties to apparent molecular weights (Fig. 5). The 
indicated sizes of the protein backbones are based on the assumption 
that only one cleavage occurs between the glycoproteins. With regard to 
E2 the C terminus remains to be determined. 
On the basis of the data outlined above we intend to study the 
biosynthesis of pestivirus glycoproteins. A particularly interesting aspect 
of this study will be the analysis of a supposed hierarchy of cleavage 
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events (manuscript in press). In addition, C-terminal truncations of 
HCV gp55 (E2) are being performed to determine its C-terminus and 
to identify signals important for heterodimerization and homodimeriza-
tion (manuscript in preparation). 
With regard to the development of vaccines against pestiviruses the 
role of individual glycoproteins in the induction of protective immunity 
will be studied. These efforts include use of (1) recombinant vaccines 
based upon different vectors, primarily vaccinia virus and Pseudorabies 
virus and (2) subunit vaccines containing pestivirus glycoprotein(s) ex­
pressed for example in insect cells after infection with recombinant 
baculo viruses. 
b. Bovine viral diarrhea virus 
Pathogenesis of mucosal disease. Comparison of the genomic sequences 
of two BVDV strains (BVDV Osloss [26] and BVDV NADL [8]) led to 
the identification of small insertions located in a region coding for a 
nonstructural protein [6, 15, 19]. The insertion of 228 nucleotides iden­
tified in the BVDV Osloss genome encodes a complete ubiquitin-like 
element with only two amino acid exchanges with respect to the ubiquitin 
sequence conserved in all animals [16, 19]. The sequence of 270 nucleo­
tides which is inserted in the BVDV NADL genome shows no homology 
to a ubiquitin gene but is almost identical with another bovine mRNA 
sequence (Fig. 6) [16]. 
In tissue culture two BVDV biotypes, cytopathogenic BVDV 
(cpBVDV) and noncytopathogenic BVDV (noncpBVDV), can be dis­
tinguished [1] (Table 1). Both biotypes are involved in pathogenesis 
of mucosal disease (MD), the most severe clinical manifestation of 
BVDV infections. A prerequisite for MD is a persistent infection with 
OSLOSS p125 
1 Ub ' 
1 [structural proteins •J ρβΟ | I 
NADL 
I 
p125 
I ι ,| 1 Γ Ί 
cms J structural proteins m 1 P80 ι ι 
Ub, ubiquitin | j | eins, cellular insertion 
Fig. 6. Insertions identified in CP BVDV strains. OSLOSS 228 nucleotides; coding for 
a ubiquitin-like protein; equivalent to one ubiquitin monomer; 2 amino acid exchanges. 
NADL 270 nucleotides; no homology to ubiquitin; 99% identity to a bovine mRNA 
sequence 
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Table 1. Characteristics of BVDV biotypes 
Non-CP CP 
Cytopathogenicity (CP) in tissue No Yes 
culture cells 
Strains (laboratory) New York NADL, Osloss, Singer, 
Oregon, Danmark 
Detection of p80 No (only pl25) Yes (in addition to pl25) 
Pathogenicity in cattle Yes Yes 
Occurrence of mucosal disease Always both biotypes isolated 
persistent infect ion wi th non-cp BVDV isolat ion of non-cp BVDV + 
no ant ibodies ( immunotolerance) cp BVDV 
Fig. 7. Pathogenesis of mucosal disease 
noncpBVDV (Fig. 7). Surprisingly, cpBVDV can always be isolated 
from MD animals in addition to the persisting noncp virus [3, 4]. In 
contrast to the described antigenic variability of BVDV field isolates the 
members of such a "pair" of noncpBVDV and cpBVDV are antigenically 
very closely related [10, 22]. This observation led to the hypothesis that 
during pathogenesis of MD a cpBVD virus develops from the noncp 
virus by acquiring some kind of mutation [10]. We proposed as a working 
hypothesis that recombination between viral and cellular RNA led to the 
formation of these cpBVDV genomes [16, 19]. 
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Fig. 8. Comparison of BVDV genomes 
To investigate directly the difference between a cytopathogenic virus 
and its noncytopathogenic counterpart we analyzed the genomes of a 
pair of cpBVDV (CP1) and noncpBVDV (NCP1) isolated from one MD 
animal. The RNA of CP1 was found to contain a ubiquitin-coding 
element which is embedded in a large duplication of viral sequence 
encompassing the p80-coding region (Fig. 8). In contrast, the genome of 
NCP 1 does not contain either insertion or duplication [17]. According to 
the results of these studies, one possible mutation leading to cytopatho­
genic BVDV is a recombination process between cellular and viral 
RNA. 
In the case of two other cpBVDV isolates from BVDV pairs no host 
cell-derived insertion could be identified. However, elaborate duplication 
and rearrangement of viral sequences were found in both genomes (for 
CP Pe515 see Fig. 8). The analysis of the noncp virus (NCP Pe515) 
revealed that neither duplication nor rearrangement of sequences are 
present, and thus supported the linkage between recombination and 
establishment of the cytopathogenic phenotype. Accordingly, generation 
of cpBVDV is not restricted to recombination between cellular and viral 
sequences but can also be achieved by mere rearrangement of viral 
sequences. 
One important change at the protein level distinguishing cpBVDV 
from noncpBVDV is the expression of p80 in cpBVDV infected cells 
(Fig. 6, Fig. 8). A prerequisite for generation of p80 is the presence of a 
cleavage site at the aminoterminus of this protein. Based on our current 
knowledge two basically different ways can be distinguished. One possi­
bility is represented by the Osloss strain where the signal for cleavage is 
provided by a cellular ubiquitin sequence inserted into the p!25 region of 
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the viral polyprotein. Ubiquitin itself is synthesized within eukaryotic 
cells in form of fusion proteins which are subsequently cleaved at the 
carboxyterminal end of the ubiquitin moiety [12, 13, 20, 24, 25]. Accord-
ingly, the insertion of ubiquitin into pl25 introduces a signal for pro-
cessing by a cellular protease (manuscript in preparation). The second 
way to generate p80 requires duplication of the respective coding region. 
Again a processing signal is necessary which is now placed in front of the 
duplicated sequence. In the case of CP1 ubiquitin provides again the 
signal for cleavage by a cellular protease (manuscript in preparation). 
For Pe515CP and CP6 a processing site encoded at the end of a second 
virus-derived duplicated element serves this purpose. This second dupli-
cated element codes for the viral protein p20. Interestingly, insertion of 
the p20-coding region also transfers the protease responsible for the 
cleavage to its point of action. The integration of both protease and 
cleavage site might be necessary because of the lack of trans function of 
the p20 protease. This would be in accordance with the hypothesis that 
p20 can only act as an autoprotease [33]. 
Both alternatives outlined above would allow identical aminoterminal 
ends for p80. The expression of this protein is strictly correlated with the 
cytopathogenic phenotype and the development of MD. Therefore p80 
represents the prime candidate for the agent responsible for killing the 
infected cells. 
Porcine reproductive and respiratory syndrome virus (PRRSV) 
Members of the arterivirus group are currently classified within the 
Togaviridae family [31], but the need for reclassification has become 
obvious after cloning and molecular analysis of the total EAV genome 
[11] and of parts of the LDV genome [14]. In contrast to togaviruses, 
arterivirus gene expression is characterized by transcription of multiple 
subgenomic mRNAs, each encoding one protein. Similar to corona-
viruses, arteriviral mRNAs form a 3' coterminal nested set and possess 
common 5' terminal leader sequences which are joined to the bodies of 
the mRNAs during transcription. Moreover, the putative EAV poly-
merase gene is probably expressed by ribosomal frameshifting as in 
coronaviruses and possesses conserved domains also present in corona-
and torovirus polymerases [11]. 
Using purified PRRS virions from infected macrophages as start-
ing material molecular cDNA cloning and sequencing was performed. 
PRRSV specific cDNA clones spanning the 3' terminal 5kb of the 
genomic RNA were isolated, sequenced and used as probes for identifi-
cation of PRRSV specific RNAs. The PRRSV genome is a positive 
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stranded polyadenylated RNA of about 15 kb. In infected cells a 3' 
coterminal nested set of six major subgenomic mRNAs could be de-
monstrated. Within the 3' terminal 3.5 kb of the PRRSV genome six 
overlapping reading frames (ORFs) were identified, each most likely 
expressed by one of the subgenomic mRNAs. Amino acid sequence 
comparisons revealed that the most 3' terminal ORF (ORF7) encodes 
the PRRSV nucleocapsid protein with a calculated molecular weight of 
14kD. It displays 44.8% amino acid identity with the capsid protein of 
lactate dehydrogenase-elevating virus (LDV) and 23.6% with that of 
equine arteritis virus (EAV). The product of ORF6, the second 3' 
terminal ORF, represents a putative membrane protein and exhibits 
53.2% and 27.2% amino acid identity with the corresponding LDV and 
EAV polypeptides. Similar to EAV, ORFs 2 through 5 might encode 
glycosylated viral proteins. The polypeptide deduced from the most 
5' ORF (ORFlb) contains two conserved domains common to EAV 
and Coronavirus polymerases. Genome organization, strategy of gene 
expression and the sequence of deduced proteins show that PRRSV 
belongs to the arterivirus group of viruses [9]. 
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